Zobrazeno 1 - 10
of 12
pro vyhledávání: '"L Campins Bernadas"'
Autor:
L Perez Cordon, A Sanchez Ulayar, S Marin Rubio, V Aguilera Jimenez, L Campins Bernadas, J Delgado Rodriguez, M Bitlloch Obiols, R Merino Mendez, T Gurrera Roig, D Lopez Faixo
Publikováno v:
Section 7: Post Congress additions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6dee1201285b08c930e6962bd8fcb71
https://doi.org/10.1136/ejhpharm-2022-eahp.400
https://doi.org/10.1136/ejhpharm-2022-eahp.400
Autor:
L Campins Bernadas, M Bitlloch Obiols, M Serra Prat, L Perez Cordon, T Gurrera Roig, V Aguilera Jimenez, S Marín Rubio, J Delgado Rodriguez
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Depression affects about 14–26% of the elderly population. It is a frequent affective disorder and one of the main reasons for medical consultation. Elderly patients usually have several comorbidities that make polypharmac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9d16aa85b156b015517969be07c5f4c
https://doi.org/10.1136/ejhpharm-2020-eahpconf.389
https://doi.org/10.1136/ejhpharm-2020-eahpconf.389
Autor:
T Gurrera Roig, M Bitlloch Obiols, A Sanchez Ulayar, J Delgado Rodriguez, L Perez Cordon, M Pujal Herranz, V Aguilera Jimenez, D Lopez Faixo, C Agusti Maragall, L Campins Bernadas
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance It is estimated that asthma affects 4.9% of adults in Spain and 3.9% are classified as severe uncontrolled asthma (SUA). Omalizumab, mepolizumab, reslizumab and benralizumab are monoclonal antibodies indicated in the treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::206eba98a1b194ba12c915e364b624dd
https://doi.org/10.1136/ejhpharm-2020-eahpconf.242
https://doi.org/10.1136/ejhpharm-2020-eahpconf.242
Autor:
D Lopez Faixo, L Perez Cordon, M Bitlloch Obiols, S Marín Rubio, M Miarons Font, A Sanchez Ulayar, C Agusti Maragall, T Gurrera Roig, J Delgado Rodriguez, L Campins Bernadas
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Hospital discharge has been described as the care transition in which a major number of incorrect prescriptions occur. Discharge medication reconciliation aims to prevent discrepancies when comparing the inhospital with the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7cfc2f8c1ab68076670a4ed12a086f8
https://doi.org/10.1136/ejhpharm-2020-eahpconf.299
https://doi.org/10.1136/ejhpharm-2020-eahpconf.299
Autor:
S Marín Rubio, J Delgado Rodriguez, L Perez Cordon, D Lopez Faixo, L Campins Bernadas, M Miarons Font
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Antipsychotics have been associated with aspiration pneumonia in older people. However, epidemiologic evidence of the association between antipsychotic drug use and pneumonia is limited. Purpose To investigate the association between antip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7014371c21393cb3f888008beb5c24a8
https://doi.org/10.1136/ejhpharm-2019-eahpconf.519
https://doi.org/10.1136/ejhpharm-2019-eahpconf.519
Autor:
M Camps Ferrer, L Perez Cordon, S Marín Rubio, L Campins Bernadas, T Gurrera Roig, J Delgado Rodriguez
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background The standard treatment for rectal cancer stage II-–III is neoadjuvant chemoradiotherapy based on oral capecitabine (CPC) or continuous 5-fluorouracil (5-FU) infusion. While efficacy has been demonstrated to be equivalent between the two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25581b2eed1f6d1a065ae6f56292781e
https://doi.org/10.1136/ejhpharm-2019-eahpconf.274
https://doi.org/10.1136/ejhpharm-2019-eahpconf.274
Autor:
L Perez Cordon, S Marín Rubio, A Sanchez Ulayar, D Lopez Faixo, T Gurrera Roig, M Miarons Font, M Camps Ferrer, C Agusti Maragall, L Campins Bernadas
Publikováno v:
Eur J Hosp Pharm
Background Nowadays, 12 different therapies are available as immune-mediated therapies (IMT) for multiple sclerosis (MS) drugs. Guidelines classify these treatments as first- and second-line. This variety allows treatment discontinuations (TD) under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06f885d13a985094763f428687dcfa52
https://europepmc.org/articles/PMC7535331/
https://europepmc.org/articles/PMC7535331/
Publikováno v:
Eur J Hosp Pharm
BACKGROUND: The prevalence of dysphagia in patients with dementia ranges from 13% to 84%. The high prevalence is likely the result of the presence of age-related lesions in the diffuse area of the brain in addition to those produced by the neuropatho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d722d22fc7b9b306769a92082a7700a
https://doi.org/10.1136/ejhpharm-2018-eahpconf.442
https://doi.org/10.1136/ejhpharm-2018-eahpconf.442
Publikováno v:
European Journal of Hospital Pharmacy. 19:157.3-158
Background Chronic infection by Hepatitis B virus (HBV) affects more than 350 million people worldwide. Recently, there have been significant advances in the understanding of this disease, a new diagnostic tool that can accurately determine the activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efef272a1255cfe3b996499a211d6dfb
https://doi.org/10.1136/ejhpharm-2012-000074.191
https://doi.org/10.1136/ejhpharm-2012-000074.191
Autor:
R. Merino Mendez, X. Fàbregas Planas, L Campins Bernadas, M. Lloret Badia, T Gurrera Roig, M Camps Ferrer, C Agusti Maragall, D Lopez Faixo, A Sanchez Ulayar
Publikováno v:
European Journal of Hospital Pharmacy. 19:213.2-214
Background The effectiveness of antiretroviral treatment depends on several factors. Incorrect adherence is the main cause of treatment failure and it has been related to an increase in mortality. Purpose To assess the compatibility of the recommenda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7383316366dabb49d70b5220c55d78f1
https://doi.org/10.1136/ejhpharm-2012-000074.337
https://doi.org/10.1136/ejhpharm-2012-000074.337